| Status | Available to order |
| EMMA ID | EM:08367 |
| International strain name | STOCK Mogtm1(cre)Gkl/Flmg |
| Alternative name | B6-Mog |
| Strain type | Targeted Mutant Strains : Other targeted |
| Allele/Transgene symbol | Mogtm1(cre)Gkl |
| Gene/Transgene symbol | Mog |
| Provider | George Kollias |
| Provider affiliation | BSRC Al. Fleming |
| Genetic information | The open reading frame of the Cre recombinase gene, followed by the human growth hormone polyadenylation signal and the neomycin resistance gene, has replaced all except the 5'-most segment of the first exon, the first intron and all but the 3'-most part of the second exon of the myelin oligodendrocyte glycoprotein gene, thus targeting Cre expression to oligodendrocytes (ODCs). Western blot analysis demonstrated that wild-type MOG protein is present in heterozygous and wild-type brains at comparable levels, but is not detectable in homozygous mutant brain. |
| Phenotypic information | Homozygous:Cre expression in oligodendrocytesHeterozygous:Cre expression in oligodendrocytes |
| References |
|
| Homozygous fertile | not known |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
| Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
| Animals used for archiving | heterozygous CBA x C57BL/6 |
